Patent Board Upholds Rejection By Examiner Of Regeneron Application
ALEXANDRIA, Va. — An effort by Regeneron Pharmaceuticals Inc. to undo a final rejection of an application to patent a method of characterizing proteins failed May 13 when the Patent Trial...To view the full article, register now.
Already a subscriber? Click here to view full article